Cellectis S.A Profit Margin 2015-2021 | CLLS
Current and historical gross margin, operating margin and net profit margin for Cellectis S.A (CLLS) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Cellectis S.A net profit margin as of June 30, 2021 is -181.89%.
|Cellectis S.A Annual Profit Margins
|Cellectis S.A Quarterly Profit Margins
||Medical - Biomedical and Genetics
Cellectis SA is a gene-editing company. The company focused on developing immunotherapies based on gene edited engineered CAR-T cells. Cellectis SA is based in Paris, France.